KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
Conclusions:
Ovarian cancers display amplified centrosomes, a feature of aggressive tumors. To cope up with the abnormal centrosomal load, ovarian cancer cells upregulate genes like KIFC1 that are known to induce centrosome clustering. Our data underscore KIFC1 as a putative biomarker that predicts worse prognosis, poor overall survival and may serve as a potential marker of onset of metastatic dissemination in ovarian cancer patients.
Source: Journal of Ovarian Research - Category: Cancer & Oncology Authors: Shrikant PawarShashikiran DonthamsettyVaishali PannuPadmashree RidaAngela OgdenNathan BowenRemus OsanGuilherme CantuariaRitu Aneja Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Ovarian Cancer | Ovaries